We are happy to announce that Mira Projects Ltd is now based in the UK. We continue to focus on future projects such as start-ups, team set-ups and management and taking key roles for clinical trials, as well as providing access to experienced and qualified specialists in other cooperated countries.

Turkey is a great potential growth area for clinical research. It is one of the fastest-growing pharmaceutical markets, ranks as the 16th largest pharmaceutical producer in the world and the 6th largest pharmaceutical market in Europe. The population in Turkey, which is around 73 million according to official statistics, is growing faster than the European Union. The total number of hospitals is 1,518 as of 2022. The healthcare system in Turkey has entered a long period of development under the Health Transformation Program, the purpose of which is to increase the quality and efficiency of the healthcare system and enhance access to healthcare facilities. There are investigators and sites keen to have clinical research studies in all cities that are accessible. Turkey can be considered as a part of Asia, Europe and MENA, with all these characteristics, the Turkish market presents valuable opportunities for clinical research. With our local knowledge and extensive local experience, Mira Projects has become a key actor in clinical research management in Turkey.

Our connections extend across the globe. In all areas of clinical research management, Mira Projects is a reliable, competent and highly experienced partner in the UK, EU, Asia and the US.